Act Capital Management, LLC Neoleukin Therapeutics, Inc. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Neoleukin Therapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 199,000 shares of NLTX stock, worth $0. This represents 0.18% of its overall portfolio holdings.
Number of Shares
199,000
Previous 199,000
-0.0%
Holding current value
$0
Previous $205,000
38.05%
% of portfolio
0.18%
Previous 0.29%
Shares
3 transactions
Others Institutions Holding NLTX
# of Institutions
1Shares Held
199KCall Options Held
0Put Options Held
0About Neoleukin Therapeutics, Inc.
- Ticker NLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 42,579,900
- Description
- Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...